Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soyeon Ko

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
International Immunopharmacology|September 23, 2024
Lidocaine combined with general anesthetics impedes metastasis of breast cancer cells via inhibition of TGF-β/Smad-mediated EMT signaling by reprogramming tumor-associated macrophagesBeom Seok Han, Soyeon Ko, Min Seok Park, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 22, 2023
Vactosertib, TGF-β receptor I inhibitor, augments the sensitization of the anti-cancer activity of gemcitabine in pancreatic cancerJi Eun Lee, Pureunchowon Lee, Young-Chan Yoon, et al.
American Journal of Cancer Research|October 13, 2022
A novel DDR1 inhibitor enhances the anticancer activity of gemcitabine in pancreatic cancerSoyeon Ko, Kyung Hee Jung, Young-Chan Yoon, et al.
EMBO Molecular Medicine|July 9, 2020
ANGPTL4 exacerbates pancreatitis by augmenting acinar cell injury through upregulation of C5aKyung Hee Jung, Mi Kwon Son, Hong Hua Yan, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
International Immunopharmacology|September 23, 2024
Lidocaine combined with general anesthetics impedes metastasis of breast cancer cells via inhibition of TGF-β/Smad-mediated EMT signaling by reprogramming tumor-associated macrophagesBeom Seok Han, Soyeon Ko, Min Seok Park, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 22, 2023
Vactosertib, TGF-β receptor I inhibitor, augments the sensitization of the anti-cancer activity of gemcitabine in pancreatic cancerJi Eun Lee, Pureunchowon Lee, Young-Chan Yoon, et al.
American Journal of Cancer Research|October 13, 2022
A novel DDR1 inhibitor enhances the anticancer activity of gemcitabine in pancreatic cancerSoyeon Ko, Kyung Hee Jung, Young-Chan Yoon, et al.
EMBO Molecular Medicine|July 9, 2020
ANGPTL4 exacerbates pancreatitis by augmenting acinar cell injury through upregulation of C5aKyung Hee Jung, Mi Kwon Son, Hong Hua Yan, et al.
Pageof 2